To evaluate the impact of GPRIN2 and FDX1 on the tumorigenic potential of LUAD cells in vivo, we established a subcutaneous transplantation tumor model using FDX1-overexpressing A549 cells with or without GPRIN2 knockdown in nude mice. The gene discussed is FDX1; the disease is neoplasm.